201 related articles for article (PubMed ID: 23265753)
1. Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma.
Tsai WL; Liang PC; Chen CH
J Formos Med Assoc; 2012 Dec; 111(12):724-5. PubMed ID: 23265753
[No Abstract] [Full Text] [Related]
2. Acute tumor lysis syndrome after transarterial chemoembolization for hepatocellular carcinoma.
Shiba H; Ishida Y; Wakiyama S; Sakamoto T; Misawa T; Yanaga K
Cancer Sci; 2008 Oct; 99(10):2104-5. PubMed ID: 19016772
[TBL] [Abstract][Full Text] [Related]
3. Acute tumor lysis syndrome caused by transcatheter oily chemoembolization in a patient with a large hepatocellular carcinoma.
Sakamoto N; Monzawa S; Nagano H; Nishizaki H; Arai Y; Sugimura K
Cardiovasc Intervent Radiol; 2007; 30(3):508-11. PubMed ID: 17242878
[TBL] [Abstract][Full Text] [Related]
4. Transarterial chemoembolization for hepatocellular carcinoma with portal vein invasion: a helpful palliative approach.
Schumacher G; Gebauer B
J Gastroenterol Hepatol; 2009 Aug; 24(8):1317-9. PubMed ID: 19702898
[No Abstract] [Full Text] [Related]
5. Acute tumor lysis syndrome after transarterial chemoembolization for well-differentiated hepatocellular carcinoma with neuroendocrine features.
Wang K; Chen Z
Onkologie; 2010; 33(10):532-5. PubMed ID: 20926901
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis.
Georgiades CS; Hong K; D'Angelo M; Geschwind JF
J Vasc Interv Radiol; 2005 Dec; 16(12):1653-9. PubMed ID: 16371532
[TBL] [Abstract][Full Text] [Related]
7. Combined transcatheter arterial chemoembolization and beta-ultrasound guided portal vein embolization in the treatment of hepatocellular carcinoma.
Mao G; Yu Z; Zhang Y; Cheng J
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):391-3. PubMed ID: 12408773
[TBL] [Abstract][Full Text] [Related]
8. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
[TBL] [Abstract][Full Text] [Related]
9. Tumor Lysis Syndrome: A Serious Complication of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
Jiang RD; Jian WC; Jin N; Zhang ZL; Li T
Am J Med; 2016 Sep; 129(9):e173-6. PubMed ID: 27155110
[No Abstract] [Full Text] [Related]
10. Uncharacteristically early fatal intraperitoneal rupture of hepatocellular carcinoma following transarterial chemoembolization.
Reichman TW; Anthony T; Millis JM; Testa G
Dig Liver Dis; 2009 Feb; 41(2):175-6. PubMed ID: 18849205
[No Abstract] [Full Text] [Related]
11. Tumor lysis syndrome after transarterial chemoembolization of hepatocellular carcinoma: case reports and literature review.
Hsieh PM; Hung KC; Chen YS
World J Gastroenterol; 2009 Oct; 15(37):4726-8. PubMed ID: 19787837
[TBL] [Abstract][Full Text] [Related]
12. Preservation of segment 4 inferior by distal middle hepatic vein reconstruction combined with extended right hepatectomy after portal vein embolization in a patient with a huge initially unresectable HCC.
Nakano H; Kikuchi K; Seta S; Katayama M; Yamamura T; Otsubo T
Hepatogastroenterology; 2007; 54(77):1563-6. PubMed ID: 17708300
[TBL] [Abstract][Full Text] [Related]
13. [A successful case of hepatocellular carcinoma with portal venous tumor thrombus (Vp2) treated by transcatheter arterial chemoembolization].
Noda T; Nagano H; Miyamoto A; Wada H; Damdinsuren B; Marubashi S; Takeda Y; Umeshita K; Dono K; Ohsuga K; Kim T; Tomoda K; Nakamura H; Monden M
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1931-4. PubMed ID: 17212150
[TBL] [Abstract][Full Text] [Related]
14. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
[TBL] [Abstract][Full Text] [Related]
15. Cytolysis following chemoembolization for hepatocellular carcinoma.
Paye F; Farges O; Dahmane M; Vilgrain V; Flejou JF; Belghiti J
Br J Surg; 1999 Feb; 86(2):176-80. PubMed ID: 10100782
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study.
Luo J; Guo RP; Lai EC; Zhang YJ; Lau WY; Chen MS; Shi M
Ann Surg Oncol; 2011 Feb; 18(2):413-20. PubMed ID: 20839057
[TBL] [Abstract][Full Text] [Related]
18. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
[TBL] [Abstract][Full Text] [Related]
19. [Complications after TACE in HCC - complications after transarterial chemoembolization (TACE) in hepatocellular carcinoma].
Schneeweiß S; Horger M; Ketelsen D; Ioanoviciu SD
Rofo; 2015 Feb; 187(2):79-82. PubMed ID: 25629286
[No Abstract] [Full Text] [Related]
20. The effectiveness of selective internal radiation therapy in challenging cases of liver-predominant unresectable hepatocellular carcinoma.
Malfertheiner P; Verslype C; Kolligs FT; Schütte K; Vandecaveye V; Paprottka PM; Ricke J
Future Oncol; 2014 Nov; 10(15 Suppl):17-27. PubMed ID: 25478762
[No Abstract] [Full Text] [Related]
[Next] [New Search]
